8-K: OneMedNet Faces Nasdaq Delisting Threat Due to Low Market Value and Equity

OneMedNet Corporation received a notification from Nasdaq regarding non-compliance with minimum market value, stockholders' equity, and net income requirements for continued listing.

Summary

• OneMedNet Corporation received a notice from Nasdaq on March 12, 2025, indicating that it does not meet the minimum requirements for continued listing on The Nasdaq Capital Market.
• The company's Market Value of Listed Securities (MVLS) was below $35 million for 31 consecutive business days prior to the notice.
• OneMedNet also fails to comply with the Nasdaq Listing Rules requiring a minimum stockholders' equity of $2.5 million and a minimum of $500,000 of net income from continuing operations.
• The company has until September 8, 2025, to regain compliance with the MVLS requirement by maintaining an MVLS at or above $35 million for at least ten consecutive business days.
• If compliance is not achieved by this date, OneMedNet may face delisting, which it can appeal.
• The company intends to monitor its MVLS and explore options to regain compliance, but there is no guarantee it will succeed.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the notification of non-compliance with Nasdaq listing rules, raising concerns about the company's financial health and future prospects.

Positives

• The notice is only a notification of deficiency and does not immediately affect the listing or trading of OneMedNet's securities.
• OneMedNet has a compliance period of 180 days, until September 8, 2025, to regain compliance.
• The company has the option to appeal any delisting determination to a hearings panel.
• OneMedNet intends to actively monitor its MVLS and evaluate available options to resolve the deficiency.

Negatives

• OneMedNet's Market Value of Listed Securities (MVLS) is below the required $35 million minimum.
• The company does not meet the minimum stockholders' equity requirement of $2.5 million.
• OneMedNet does not meet the minimum net income from continuing operations requirement of $500,000.
• Failure to regain compliance by September 8, 2025, could lead to delisting from Nasdaq.

Risks

• There is no assurance that OneMedNet will be able to regain or maintain compliance with Nasdaq listing standards.
• Delisting from Nasdaq could negatively impact the company's stock price and investor confidence.
• The company's ability to raise capital may be hindered if it is delisted.
• Continued non-compliance could lead to further regulatory scrutiny.

Future Outlook

The company intends to actively monitor its MVLS and evaluate available options to resolve the deficiency and regain compliance with the MVLS requirement; however, there is no assurance that the company will be able to regain or maintain compliance with Nasdaq listing standards.

Management Comments

• Aaron Green, Chief Executive Officer, signed the report on behalf of OneMedNet Corporation.

Industry Context

Many smaller companies, especially in volatile sectors like technology and healthcare, face challenges in maintaining the minimum listing requirements of exchanges like Nasdaq. This situation highlights the importance of financial performance and market capitalization for continued listing.

Comparison to Industry Standards

• Companies like OneMedNet, with a market capitalization below $35 million, often struggle to maintain Nasdaq listing compliance.
• Compared to larger, more established healthcare technology companies, OneMedNet's financial metrics fall short of industry benchmarks for continued listing.
• Other companies facing similar delisting challenges often explore options such as reverse stock splits, capital raises, or mergers to regain compliance.

Stakeholder Impact

• Shareholders may experience a decline in stock value if the company is delisted.
• Employees may face uncertainty regarding their job security.
• The company's ability to attract and retain customers and suppliers may be affected.
• Creditors may become more cautious about extending credit to OneMedNet.

Next Steps

• OneMedNet will actively monitor its MVLS.
• The company will evaluate available options to resolve the deficiency and regain compliance with the MVLS requirement.
• OneMedNet may appeal any delisting determination to a hearings panel if necessary.

Key Dates